Mr. Gallagher (for himself, Mr. Quigley, Mr. Westerman, and Mr. Swalwell) introduced the following bill; which was referred to the Committee on Energy and Commerce
To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
21 U.S.C. 351
and
355 42 U.S.C. 1320a-7b, 1396r-8
and
300gg-19a
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Promising Pathway Act. H.R. 3761. 117th
Cong., 1st
sess., Introduced in House June 8, 2021. https://www.govinfo.gov/app/details/BILLS-117hr3761ih.
APA
Congress, House of Representatives (2021, June 8). Promising Pathway Act (H.R. 3761 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-117hr3761ih.
MLA
United States, Congress, House of Representatives. Promising Pathway Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-117hr3761ih. 117th Congress, H.R. 3761, Introduced in House 8 Jun. 2021.
